Top 10 Angel Investors in Isle of Man (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Chris Adelsbach
Angel
|
1 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Series A | FinTech, Financial Services, Software | $120k–$20M |
|
Stuart Gardner
Angel
|
1 | United States, United Kingdom, Isle of Man | Pre-Seed, Seed, Angel | Funding Platform, Financial Services, Solar | $601k–$1M |
|
Charles Delingpole
Angel
|
1 | United Kingdom, United States, Spain | Seed, Pre-Seed, Series A | Financial Services, FinTech, Payments | $382k–$20M |
|
Tom James
Angel
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Angel | SaaS, Software, Information Technology | $276k–$1.5M |
|
Jim Mellon
Angel
|
1 | United States, United Kingdom, Israel | Series A, Seed | Biotechnology, Food and Beverage, Health Care | $536k–$46M |
|
Paolo Rubatto
Angel
|
1 | United States, United Kingdom, India | Seed, Pre-Seed, Series A | Software, SaaS, Mobile | $200k–$8M |
|
Will Neale
Angel
|
1 | United Kingdom, Italy, Japan | Seed, Pre-Seed | FinTech, Financial Services, Software | $121k–$6.2M |
|
Greg Bailey
Angel
|
1 | United States, Isle of Man | Series A, Post-IPO Equity, Seed | Biotechnology, Pharmaceutical, Health Care | $3M–$80M |
|
James Isilay
Angel
|
1 | United Kingdom, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $601k–$10M |
|
Wendy O
Angel
|
1 | Isle of Man | Seed | Media and Entertainment | |
| Access all 15 angel investors in Isle of Man startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Chris Adelsbach - Founding Partner @ Outrun Ventures
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 226
- Round size: Seed $120k–$6.1M; Pre-Seed $120k–$2M; Series A $4.3M–$20M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Capsa AI — Providing next-generation investors with a competitive edge.
- FinCrime Dynamics — Our mission is to help make the world’s financial system safer through rapid deployment of effective AI for financial crime analytics, enabled by enriched synthetic data that captures the dynamics of fraud and money laundering and loads them into tailor-made scenarios that explore diverse threats that financial organisations are exposed to.Thisgoal has taken us to the forefront of Synthetic Data and Fincrime Analytics, and we are proud to have in our team people that have helped shape the state-of-the-art of these fields.Keywords: Finacial services, AML, Synthetic Data, Fintech, Machine learning, Big data, Simulation, Fraud Analytics, Compliance
- Applied Computing — Applied Computing delivers industrial AI to the energy industry including oil and gas, refineries, and petrochemical plants, helping critical operations harness 100% of their data and optimise in real time for safer, faster, higher-performing decisions
Stuart Gardner
Show more...Investment focus
- Industry: Funding Platform, Financial Services, Solar
- Stage:Pre-Seed, Seed, Angel
- Geography: United States, United Kingdom, Isle of Man
Investor stats
- Total investments: 9
- Round size: Seed $960k–$1M; Pre-Seed $601k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
- MONET — Embedded finance for agencies and B2B platforms. Frictionless access to white-labelling B2B credit, global payments and new revenue streams. Offer white-label invoice finance to your network, driving growth for you and your suppliers.
- VIAN Therapeutics — VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market.
Charles Delingpole is Founder and CEO of ComplyAdvantage, a technology company focused on wiping out financial crime using Machine Learning. As CEO, Charles leads the product development and growth of the company. His passion for the issue came from his time as the MLRO of a previous startup he founded when he realized how inefficient processesaround money laundering are. Charles previously worked at The Student Room as a Founder and CEO. He attended the University of Cambridge and The London School of Economics and Political Science (LSE).Over 99% of money laundering is successful, ComplyAdvantage is working to stop it completely. Founded in 2014 with offices in London, New York, Singapore, and Cluj, ComplyAdvantage work with over 350 firms across 45 countries. Charles set up his first company, The Student Room Group, now the world’s largest student discussion forum when he was 16. After completing his MA in Politics at Trinity College Cambridge, and then an MSc in Management, Strategy, and Finance from the LSE, he became an associate at J.P. Morgan Cazenove.
Show more...Investment focus
- Industry: Financial Services, FinTech, Payments
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 41
- Round size: Seed $2M–$10M; Pre-Seed $382k–$2.3M; Series A $6.4M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ascendx Cloud — Supercharge Salesforce with connected apps that streamline sales, automate data, and drive enterprise-scale growth - Salesforce Solutions By Ascendx
- Firenze — Firenze aims to expand financial services by extending investment-backed lending to a wider audience, recognizing its importance in wealth creation and preservation. The founding team aims to democratize Lombard lending, making it accessible to all, while focusing on mass affluent clients.
- Isembard — Isembard has experience from the military, government, large enterprises, and a successfully exited technology business.
Tom James - Advisor @ OneLogin
Show more...Investment focus
- Industry: SaaS, Software, Information Technology
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 10
- Round size: Seed $500k–$1.5M; Pre-Seed $276k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cargofy — Cargofy it's a mobile assistant, kind of a "Siri" but for truck drivers. We help truckers access to high paying loads through our app, and receive discounts on fuel, maintenance, and truck parts.
- seedata.io — Seedata.io's automated deception platform plants, maintains and monitors honeypot traps throughout your estate, catching attackers before damage is done.
- MONET — Embedded finance for agencies and B2B platforms. Frictionless access to white-labelling B2B credit, global payments and new revenue streams. Offer white-label invoice finance to your network, driving growth for you and your suppliers.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 32
- Round size: Seed $536k–$20M; Series A $4.6M–$46M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- OncoSenX — OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease.
- Netwealth — Netwealth provides expert investment management and tailored wealth planning solutions, helping you confidently achieve your financial goals.
- Repair Biotechnologies — Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling humanbeings to improve their health span through targeting the causes of age-related diseases and ageing itself.
Paolo Rubatto is Managing Director of Start Capital. His background is mainly entrepreneurial, advising startups from the consumer internet to the life sciences sector in their business development strategies as well as in their fundraising. He holds an MBA from London Business School.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 12
- Round size: Seed $200k–$1.6M; Series A $1.7M–$8M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- SAPI — SAPI builds credit products for payment companies to facilitate payment flows, engage and retain merchants, and generate new revenue.
- Coindirect — BVNK is a next-generation payments platform. We're making payments as accessible and resilient as the internet.
- Kosmik — Transform your creative workflow with Kosmik's AI moodboard maker. Built-in browser, real-time collaboration, and infinite canvas for moodboarding.
Founder (Grabyo, Fonix). Investor.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Italy, Japan
Investor stats
- Total investments: 52
- Round size: Seed $121k–$6.2M; Pre-Seed $650k–$4.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
- Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
- SAPI — SAPI builds credit products for payment companies to facilitate payment flows, engage and retain merchants, and generate new revenue.
Dr. Gregory H. Bailey is a Managing Partner at Palantir Group, Inc. Dr. Bailey is the Co-founder of Ascent Healthcare Solutions; VirnetX Inc. (AMEX:VHC) and Duramedic Inc. He was also the initial public financier and an independent director of Medivation, Inc. (NASDAQ:MDVN), from 2005 to December 2012. Dr. Bailey served as the Managing Director andco-Head of Life Sciences at MDB Capital Group LLC from May 2004 to January 2007. Previously he served as Life Sciences Analyst at Participating Capital, Corp. He has served on the board of directors of multiple public companies. Dr. Bailey has Medical Doctorate from the University of Western Ontario and practiced medicine as an emergency physician for ten years.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Post-IPO Equity, Seed
- Geography: United States, Isle of Man
Investor stats
- Total investments: 9
- Round size: Series A $3M–$19M; Post-IPO Equity $15M–$80M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Juvenescence — We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
- Serina Therapeutics — Serina Therapeutics is a privately-held pharmaceutical company that is advancing novel therapeutics for cancer, inflammation, pain, and metabolic disorders using its proprietary polymer technology. They have created new pharmaceutical candidates using polyoxazoline (POZ), a safe, water-soluble polymer to which they can attach a variety of smallmolecules, proteins, peptides, and DNA. The attachment of these molecules to polymers of POZ typically confers a unique pharmacokinetic profile that is markedly different from the parent compound, and this profile may confer advantages in terms of safety and efficacy.
- Bristol-Myers Squibb — Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
James Isilay serves as the Chief Executive Officer at Cognism.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Switzerland, United States
Investor stats
- Total investments: 10
- Round size: Seed $1M–$10M; Pre-Seed $601k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- viso.ai — Unlock the potential of computer vision with Viso Suite, empowering industries with real-time insights for enhanced efficiency, safety, and innovation.
- viso.ai — Unlock the potential of computer vision with Viso Suite, empowering industries with real-time insights for enhanced efficiency, safety, and innovation.
- Hyperbound — Hyperbound AI analyzes thousands of calls, uncovers why your top reps win, and builds AI roleplays to help you scale fast and reinforce your playbooks.
Wendy O - Marketing and Community Growth @ MonetaryUnit
Show more...Investment focus
- Industry: Media and Entertainment
- Stage:Seed
- Geography: Isle of Man
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bloktopia — Bloktopia is the virtual reality metaverse that will allow users to Learn, Earn, Play, and Create and provides a central hub for everything cryptocurrency
Angel investor funding in Isle of Man at a glance
Stats across 7 deals from 15 investors.
Access all 15 angel investors in Isle of Man startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Angel Investors in Isle of Man investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 15 angel investors investing in Isle of Man startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!